BARROW ROBERT (Chief Executive Officer) sold 3.1% of their position (24.43K shares) of DEFINIUM THERAPEUTICS, INC. on the open market
Open‑market sale worth $451.2K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/26/2026ACC: 0001193125-26-126825
DirectorOfficer· Chief Executive Officer
Since Jan 2022
-24.43K
Net shares
Net seller
$451.2K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
24.43K disposed
Non-Derivative Transactions1
Common Shares
Direct
Shares
−24.43K
Price / share
$18.47
Trade value
$451.24K
% of position
3.1%
3/25/2026
776.88K→752.45K
Total
Net shares
−24.43K
Net value
-$451.24K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Shares Direct | 3/25/2026 | S · Sale | −24.43K | $18.47 | $451.24K | 3.1% | 776.88K | 752.45K |
| Total | −24.43K | -$451.24K | ||||||
Derivative Transactions0
No derivative transactions reported